Drs. Berrocal Reflect on ASRS 2026 - Scorecard - MDSpire

Drs. Berrocal Reflect on ASRS 2026

ASRS 2026 meeting program chair Audina M. “Nina” Berrocal, MD, FASRS, joins Maria H. Berrocal, MD, to discuss the meeting’s highlights, surgical sessions, and educational approach.

  • By

  • Audina M. Berrocal, MD

  • Maria H. Berrocal, MD

  • July 15, 2026

  • 3 min

Share

Clinical Scorecard: Drs. Berrocal Reflect on ASRS 2026

At a Glance

CategoryDetail
ConditionRetina Surgery
Key MechanismsInnovative surgical techniques and educational approaches in retina surgery.
Target PopulationYoung and diverse surgeons in the field of retina.
Care SettingAnnual ASRS meeting

Key Highlights

  • Showcasing young and diverse surgeons from around the world.
  • Focus on innovative surgical techniques and discussions.
  • Emphasis on women in retina surgery.
  • Short talks followed by robust discussions.
  • International participation in surgical presentations.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • Encourage participation of young and diverse surgeons.
          • Utilize short presentations to foster discussion.
          • Highlight the contributions of women in the field.

          Related Resources & Content

            Original Source(s)

            Drs. Berrocal Reflect on ASRS 2026

            • by Audina M. Berrocal, MD, Maria H. Berrocal, MD

            • July 15, 2026

            Related Content

            Systemic factors associated with poor anatomical response to anti-VEGF therapy in patients with diabetic macular edema: evidence from a large clinical cohort

            A First Look at Phase 2 ArMaDa Data

            Arshad M. Khanani, MD, FASRS, discusses phase 2 findings for OCU410, an investigational gene therapy for geographic atrophy. A phase 3 program is expected to begin later this year.

            The Economics of Home OCT

            At ASRS 2026, Sean Berkowitz, MD, MBA, examined the payer costs and physician workload associated with home OCT monitoring for wet AMD.